A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox

Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

NCT06721585 ·Status: COMPLETED

Study of Tecovirimat for Human Mpox Virus

NCT05534984 ·Status: TERMINATED ·Phase: PHASE3

SIGA-246 to Treat Smallpox

NCT00303225 ·Status: WITHDRAWN ·Phase: PHASE1

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

NCT04485039 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

NCT04957485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

NCT00857493 ·Status: COMPLETED ·Phase: PHASE2

Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT

NCT05745987 ·Status: RECRUITING ·Phase: PHASE4

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

NCT00189956 ·Status: COMPLETED ·Phase: PHASE2

Dryvax Dilution-Prev Vacc Adults

NCT00032708 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

NCT05762523 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders

NCT00189917 ·Status: COMPLETED ·Phase: PHASE1

Human Immune Responses Smallpox

NCT00068198 ·Status: COMPLETED ·Phase: PHASE1

A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults

NCT00026611 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine

NCT06771479 ·Status: RECRUITING ·Phase: PHASE1

Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

NCT00042094 ·Status: COMPLETED ·Phase: PHASE1

Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

NCT01827371 ·Status: COMPLETED ·Phase: PHASE2

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

NCT03699124 ·Status: COMPLETED ·Phase: PHASE3

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

NCT00914732 ·Status: COMPLETED ·Phase: PHASE2

Immune Responses to Smallpox Vaccination

NCT00325975 ·Status: COMPLETED

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

NCT00189969 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of Typhax, a Typhoid Vaccine

NCT03926455 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis

NCT00316602 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects

NCT00316524 ·Status: COMPLETED ·Phase: PHASE2

Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years

NCT05846243 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

NCT00879762 ·Status: COMPLETED ·Phase: PHASE2